{
  "disease_name": "X-linked adrenoleukodystrophy",
  "orpha_code": "43",
  "trials": [
    {
      "nctId": "NCT05819866",
      "briefTitle": "A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy",
      "officialTitle": "A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy",
      "overallStatus": "RECRUITING",
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "conditions": [
        "Cerebral Adrenoleukodystrophy (cALD)"
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Leriglitazone"
        },
        {
          "type": "DRUG",
          "name": "Placebo"
        }
      ],
      "enrollment": 40,
      "locations": [
        {
          "facility": "Stanford University Medical Center",
          "city": "Palo Alto",
          "country": "United States"
        },
        {
          "facility": "Neuro Medicine Hospital / UF Health",
          "city": "Gainesville",
          "country": "United States"
        },
        {
          "facility": "Kennedy Krieger Institute",
          "city": "Baltimore",
          "country": "United States"
        },
        {
          "facility": "Massachusetts General Hospital",
          "city": "Boston",
          "country": "United States"
        },
        {
          "facility": "University of Minnesota",
          "city": "Minnesota",
          "country": "United States"
        },
        {
          "facility": "Health University of Utah",
          "city": "Salt Lake City",
          "country": "United States"
        },
        {
          "facility": "Hospital Austral",
          "city": "Buenos Aires",
          "country": "Argentina"
        },
        {
          "facility": "Federal University of Sao Paulo",
          "city": "São Paulo",
          "country": "Brazil"
        },
        {
          "facility": "ICM La Pitie Salpetriere",
          "city": "Paris",
          "country": "France"
        },
        {
          "facility": "Klinik und Poliklinik für Neurologie-Leipzig",
          "city": "Leipzig",
          "country": "Germany"
        },
        {
          "facility": "Sir Ganga Ram Hospital",
          "city": "New Delhi",
          "country": "India"
        },
        {
          "facility": "Hospital 12 de Octubre",
          "city": "Madrid",
          "country": "Spain"
        },
        {
          "facility": "National Hospital for Neurology and Neurosurgery",
          "city": "London",
          "country": "United Kingdom"
        }
      ],
      "lastUpdateDate": "2025-04-08"
    },
    {
      "nctId": "NCT06513533",
      "briefTitle": "Dimethyl Fumarate in Adrenomyeloneuropathy",
      "officialTitle": "Effect of Dimethyl Fumarate Administered to Patients With Adrenomyeloneuropathy: a Multicenter, Placebo Controlled, Phase IIb/III Trial",
      "overallStatus": "RECRUITING",
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Adrenomyeloneuropathy Without Cerebral Involvement"
      ],
      "interventions": [
        {
          "type": "OTHER",
          "name": "Placebo"
        },
        {
          "type": "DRUG",
          "name": "Dimethyl fumarate"
        }
      ],
      "enrollment": 40,
      "locations": [
        {
          "facility": "Bellvitge University Hospital",
          "city": "L'Hospitalet De Llobregat",
          "country": "Spain"
        },
        {
          "facility": "Donostia University Hospital",
          "city": "Donostia",
          "country": "Spain"
        },
        {
          "facility": "University Hospital 12 de Octubre",
          "city": "Madrid",
          "country": "Spain"
        }
      ],
      "lastUpdateDate": "2024-07-25"
    }
  ],
  "processing_timestamp": "2025-07-07T03:13:16.387834",
  "run_number": 1,
  "total_trials_found": 2
}